From: Association of β-cell function and cognitive impairment in patients with abnormal glucose metabolism
Variables | HOMA-β | P | ||||
---|---|---|---|---|---|---|
Total (n = 592) | Q1 (n = 148) | Q2 (n = 148) | Q3 (n = 148) | Q4 (n = 148) | ||
Age (years) | 60.20 ± 7.63 | 61.56 ± 7.65 | 60.07 ± 7.06 | 59.67 ± 7.52 | 59.48 ± 8.16 | 0.079 |
Male, n (%) | 181 (30.6) | 57 (38.5) | 44 (29.7) | 47 (31.8) | 33 (22.3) | 0.025* |
BMI (kg/m2), n (%) | <0.001* | |||||
≥ 25 | 429 (72.5) | 93 (62.8) | 101 (68.2) | 112 (75.7) | 123 (83.1) | |
< 25 | 163 (27.5) | 55 (37.2) | 47 (31.8) | 36 (24.3) | 25 (16.9) | |
Education level, n (%) | 0.073 | |||||
Primary education or below | 83 (14.0) | 27 (18.2) | 14 (9.5) | 15 (10.1) | 27 (18.2) | |
Elementary education | 357 (60.3) | 85 (57.4) | 89 (60.1) | 100 (67.6) | 83 (56.1) | |
High school education or above | 152 (25.7) | 36 (24.3) | 45 (30.4) | 33 (22.3) | 38 (25.7) | |
Smoking, n (%) | 0.662 | |||||
Never | 488 (82.4) | 118 (79.7) | 121 (81.8) | 123 (83.1) | 126 (85.1) | |
Former or current | 104 (17.6) | 30 (20.3) | 27 (18.2) | 25 (16.9) | 22 (14.9) | |
Drinking, n (%) | 0.231 | |||||
Never | 478 (80.7) | 112 (75.7) | 120 (81.1) | 120 (81.1) | 126 (85.1) | |
Former or current | 114 (19.3) | 36 (24.3) | 28 (18.9) | 28 (18.9) | 22 (14.9) | |
HDL-C (mmol/L) | 1.39 ± 0.32 | 1.43 ± 0.35 | 1.45 ± 0.31 | 1.38 ± 0.32 | 1.31 ± 0.30 | < 0.001* |
LDL-C (mmol/L) | 3.32 ± 0.91 | 3.36 ± 1.03 | 3.45 ± 0.93 | 3.29 ± 0.83 | 3.19 ± 0.82 | 0.150 |
Dyslipidemia, n (%) | 456 (77.0) | 115 (77.7) | 107 (72.3) | 112 (75.7) | 122 (82.4) | 0.212 |
Hypertension, n (%) | 256 (43.2) | 61 (41.2) | 55 (37.2) | 65 (43.9) | 75 (50.7) | 0.120 |
Heart disease, n (%) | 78 (13.2) | 25 (16.9) | 13 (8.8) | 17 (11.5) | 23 (15.5) | 0.146 |
High-Hcy, n (%) | 166 (28.0) | 38 (25.7) | 43 (29.1) | 42 (28.4) | 43 (29.1) | 0.903 |
Cognitive Impairment, n (%) | 356 (60.1) | 102 (68.9) | 89 (60.1) | 84 (56.8) | 81 (54.7) | 0.064 |
HOMA-IR | 2.27 ± 2.03 | 1.81 ± 1.44 | 1.71 ± 0.94 | 2.09 ± 1.13 | 3.48 ± 3.22 | <0.001* |